Measurement of soluble perforin, a marker of CD8 + T lymphocyte activation in epithelial lining fluid

Respiratory Medicine

Volumn 105, Issue 12, 2011, Pages 1885-1890

  Shiratsuchi, Nahoko ^a   Asai, Kazuhisa ^a   Kanazawa, Hiroshi ^a   Kyoh, Shigenori ^a   Tochino, Yoshihiro ^a   Kodama, Toyoki ^a   Hirata, Kazuto ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD8 + T lymphocyte; COPD (chronic obstructive pulmonary disease); ELF (epithelial lining fluid); Perforin

Indexed keywords

PERFORIN;

AGED; ARTICLE; BODY FLUID; BRONCHOSCOPY; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSING CAPACITY FOR CARBON MONOXIDE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY EPITHELIUM LINING FLUID; RESPIRATORY TRACT PARAMETERS; T LYMPHOCYTE ACTIVATION;

AGED; BIOLOGICAL MARKERS; BRONCHOSCOPY; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LYMPHOCYTE ACTIVATION; MALE; PERFORIN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SMOKING; VITAL CAPACITY;

EID: 81155150131     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.06.008     Document Type: Article

References (12)

1. M. Saetta, G. Turato, P. Maestrelli, C.E. Mapp, and L.M. Fabbri Cellular and structural bases of chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 2001 1304 1309 (Pubitemid 32506590)
2. J.C. Hogg, F. Chu, S. Utokaparch, R. Woods, W.M. Elliot, and L. Buzatu The nature of small-airway obstruction in chronic obstructive pulmonary disease N Engl J Med 350 2004 2645 2653 (Pubitemid 38787999)
3. J.C. Hogg Pathophysiology of airflow limitation in chronic obstructive pulmonary disease Lancet 364 2004 709 721 (Pubitemid 39140629)
4. M. Saetta, A.D. Stefano, G. Turato, F.M. Facchini, L. Corbino, and C.E. Mapp CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 822 826
5. I. Retamales, W.M. Elliott, B. Meshi, H.O. Coxson, P.D. Pare, and F.C. Sciurba Amplification of inflammation in emphysema and its association with latent adenoviral infection Am J Respir Crit Care Med 164 2001 469 473 (Pubitemid 32778218)
6. E.G. Tzortzaki, and N.M. Siafakas A hypothesis for the initiation of COPD Eur Respir J 24 2009 310 315
7. S. Hodge, G. Hodge, J. Nairn, M. Holmes, and P.N. Reynolds Increased airway granzyme b and perforin in current and ex-smoking COPD subjects J Chronic Obstructive Pulm Dis 3 2006 179 187 (Pubitemid 44949057)
8. + lymphocytes in patients with COPD Chest 125 2004 71 76 (Pubitemid 38114566)
9. T. Kodama, H. Kanazawa, Y. Tochino, S. Kyoh, K. Asai, and K. Hirata A technological advance comparing epithelial lining fluid from different regions of the lung in smokers Respir Med 103 2009 35 40
10. A. Sharafkhaneh, N.A. Hanania, and V. Kim Pathogenesis of emphysema Proc Am Thorac Soc 5 2008 475 478
11. I. Vachier, A.M. Vignola, G. Chiappara, A. Bruno, H. Meziane, and P. Godard Inflammatory features of nasal mucosa in smokers with and without COPD Thorax 59 2004 303 307 (Pubitemid 38496747)
12. B. Lundbck, A. Lindberg, M. Lindstrm, E. Rnmark, A.C. Jonsson, and E. Jnsson Not 15 but 50% of smokers develop COPD? - report from the obstructive lung disease in northern Sweden studies Repir Med 97 2003 115 122 (Pubitemid 36284990)